Dashboard
Manage Tickers

ALNYALNYLAM PHARMACEUTICALS, INC.

Nasdaq alnylam.com


$ 240.15 $ 17.25 (7.74 %)    

Tuesday, 25-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 240.15
$ 221.68
$ 232.80 x 233
$ 0.00 x 0
$ 221.12 - $ 241.68
$ 141.98 - $ 242.00
4,500,688
na
30.29B
$ 0.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-10-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-14-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-15-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-15-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

citigroup-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-291
Citigroup Maintains Buy on Alnylam Pharmac...
06/25/2024 18:41:08

Citigroup analyst David Lebovitz maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from...

b-of-a-securities-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-295
B of A Securities Maintains Buy on Alnylam...
06/25/2024 16:55:33

B of A Securities maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $248 to $295.

leerink-partners-maintains-market-perform-on-alnylam-pharmaceuticals-raises-price-target-to-159
Leerink Partners Maintains Market Perform ...
06/25/2024 15:53:59

Leerink Partners maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Market Perform and raises the price target from $138 ...

td-cowen-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-282
TD Cowen Maintains Buy on Alnylam Pharmace...
06/25/2024 15:39:34

TD Cowen analyst Ritu Baral maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $260...

evercore-isi-group-maintains-outperform-on-alnylam-pharmaceuticals-raises-price-target-to-260
Evercore ISI Group Maintains Outperform on...
06/25/2024 14:36:55

Evercore ISI Group analyst Liisa Bayko maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the pric...

barclays-maintains-overweight-on-alnylam-pharmaceuticals-raises-price-target-to-291
Barclays Maintains Overweight on Alnylam P...
06/25/2024 14:35:34

Barclays analyst Gena Wang maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Overweight and raises the price target fro...

rbc-capital-maintains-outperform-on-alnylam-pharmaceuticals-raises-price-target-to-250
RBC Capital Maintains Outperform on Alnyla...
06/25/2024 14:13:44

RBC Capital analyst Luca Issi maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the price target ...

wells-fargo-maintains-equal-weight-on-alnylam-pharmaceuticals-raises-price-target-to-207
Wells Fargo Maintains Equal-Weight on Alny...
06/25/2024 13:52:50

Wells Fargo analyst Tiago Fauth maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Equal-Weight and raises the price tar...

morgan-stanley-maintains-equal-weight-on-alnylam-pharmaceuticals-raises-price-target-to-250
Morgan Stanley Maintains Equal-Weight on A...
06/25/2024 09:29:34

Morgan Stanley analyst Michael Ulz maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Equal-Weight and raises the price ...

nvidia-affirm-holdings-carnival-corp-alnylam-pharmaceuticals-tesla-why-these-5-stocks-are-on-investors-radars-today
Nvidia, Affirm Holdings, Carnival Corp, Al...
06/25/2024 02:18:47

On Monday, major U.S. indices showed mixed performance. The Dow Jones Industrial Average closed up by nearly 0.7% at 39,411.21,

needham-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-275
Needham Maintains Buy on Alnylam Pharmaceu...
06/24/2024 18:33:45

Needham analyst Joseph Stringer maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from ...

semiconductor-nvidia-woes-deepen-nasdaq-100-slips-dow-rallies-bitcoin-sinks-to-60400-whats-driving-markets-monday
Semiconductor, Nvidia Woes Deepen; Nasdaq ...
06/24/2024 17:17:16

Wall Street faces a continuation of last week’s trend during Monday’s morning trading, with semiconductor stocks selling off he...

hc-wainwright--co-reiterates-buy-on-alnylam-pharmaceuticals-maintains-400-price-target
HC Wainwright & Co. Reiterates Buy on Alny...
06/24/2024 17:16:48

HC Wainwright & Co. analyst Patrick Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $...

bmo-capital-maintains-outperform-on-alnylam-pharmaceuticals-maintains-234-price-target
BMO Capital Maintains Outperform on Alnyla...
06/24/2024 17:15:42

BMO Capital analyst Kostas Biliouris maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and maintains $234 pr...

alnylams-closely-watched-phase-3-heart-disease-trial-of-vutrisiran-hits-primary-endpoint-shares-surge
Alnylam's Closely Watched Phase 3 Heart Di...
06/24/2024 13:49:11

Alnylam Pharmaceuticals reports positive results from the HELIOS-B Phase 3 study of vutrisiran for ATTR amyloidosis with cardio...

Core News & Articles
Market-Moving News for June 24th
06/24/2024 12:39:04

ALNY: 14% | Alnylam Pharmaceuticals shares are trading higher after the company announced topline results from its HELIOS-B Pha...

rxo-alnylam-pharmaceuticals-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
RXO, Alnylam Pharmaceuticals And Other Big...
06/24/2024 11:54:53

trading-halt-halt-status-updated-at-72501-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
06/24/2024 11:25:08

alnylam-announces-topline-results-from-its-helios-b-phase-3-study-of-vutrisiran-study-achieved-statistical-significance-on-primary-and-all-secondary-endpoints
Alnylam Announces Topline Results From Its...
06/24/2024 11:02:46

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
06/24/2024 10:55:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)